![Christopher Rovaldi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Rovaldi
Nessuna posizione attualmente
Profilo
Christopher Rovaldi è SVP-Program Management & Operations alla Acceleron Pharma, Inc. Il sig. Rovaldi ha precedentemente ricoperto la posizione di Direttore-Project Management presso Idenix Pharmaceuticals LLC, Senior Research Associate di Periodontix, Inc. e Direttore-Project Management presso Cubist Pharmaceuticals LLC. Ha conseguito una laurea e un diploma di laurea presso l'Università del New Hampshire.
Precedenti posizioni note di Christopher Rovaldi
| Società | Posizione | Fine |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Presidente | 18/08/2025 |
| ACCELERON PHARMA INC. | Direttore operativo | 01/05/2018 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2007 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2004 |
Periodontix, Inc.
 Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Corporate Officer/Principal | - |
Formazione di Christopher Rovaldi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Periodontix, Inc.
Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Commercial Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
